About Glycom
Glycom is a company based in Lyngby (Denmark) founded in 2005 was acquired by DSM in February 2020. Glycom offers products and services including Human Milk Oligosaccharides and Vitamins.
- Latest Funding Round$323.71K (USD), Grant
Jan 2023
- Investorsdsm-firmenich
& 2 more
- Acquired byDSM
(Feb 2020)
Products & Services of Glycom
Glycom offers a comprehensive portfolio of products and services, including Human Milk Oligosaccharides and Vitamins.
HMOs are produced for use in early life nutrition and dietary supplements to support health benefits such as gut and immune functions.
Vitamins are supplied as part of a portfolio for health and nutrition applications in various markets.
Apps and channels of Glycom
its YouTube channel dsm-firmenich has 3.18K subscribers and 30 videos.
Videos from Glycom
The most watched videos on Glycom's YouTube channel, dsm-firmenich (3.18K subscribers). Click a video to play it here.
More on dsm-firmenich.
Funding Insights of Glycom
- Total Rounds 3
- Last Round Grant — $323,713
- Investors Count 2
All 3 funding rounds of Glycom with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2023 | $323,713 | Grant | – | – | |
| Jan 2019 | $340,985 | Grant | – | – | |
| Jun 2005 | – | Seed | – | – |
3 investors in total: 3 institutional.
Investors in Glycom
Glycom has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include dsm-firmenich, European Union and PreSeed Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
- | – | preseedventures.dk | - | |
Health, nutrition, and bioscience solutions are delivered worldwide. | 1902 | dsm.com | Heerlen, Netherlands |
Investor details for Glycom
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Glycom
4 dated milestones of Glycom across 18 years, from founding to its latest funding, stage changes and deals.
- Founded Glycom is founded.
- Funding First funding round.
- Exit Acquired by DSM.
- Funding Latest funding round, Grant, of $324K.
Similar companies to Glycom
10 companies that operate in the same segment as Glycom (Traditional Health & Nutrition), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | – | USD 3.02 B | 8,300 | |
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | – | USD 5.1 B | 13,500 | |
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals. | 1901 | Petah Tikva, Central District, Israel | USD 500 M | USD 18.74 B | 51,792 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | – | USD 508.93 M | 5,180 | |
Pharmaceutical products are developed and marketed globally. | 2009 | Montville, New Jersey, United States | USD 155.92 M | – | – | |
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | – | USD 6.21 B | 25,870 | |
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations | 1991 | Delhi, Delhi, India | USD 367.2 M | USD 1.52 B | 21,320 | |
Generics, biosimilars, APIs, and vaccines are manufactured by Wockhardt. | 1967 | Mumbai, Maharashtra, India | – | USD 353.53 M | 3,410 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Glycom
Glycom was founded in 2005.
Glycom is headquartered in Lyngby, Denmark. It is registered at Lyngby, Region Hovedstaden, Denmark.
Glycom was founded in 2005 in Lyngby, Denmark, within the active entertainment sector. Climbing walls for indoor and outdoor use are designed and produced, encompassing bouldering, rope, and speed variants. Solutions for ropes courses, ninja courses, and adventure hubs are developed for diverse venues. Turnkey services are provided, including design, engineering, production, installation, and certification. Additional products such as climbing holds, safety mats, and gym software are offered.
Glycom offers Human Milk Oligosaccharides and Vitamins.
Glycom has 3 investors. Key investors include dsm-firmenich, European Union, and PreSeed Ventures.
Glycom operates through Dsm-Firmenich.
Yes. Glycom was acquired by DSM in February 2020.